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Abstract: This article reviews tendon and ligament injury incidence and severity within elite rugby
union and rugby league. Furthermore, it discusses the biological makeup of tendons and ligaments
and how genetic variation may influence this and predisposition to injury. Elite rugby has one of the
highest reported injury incidences of any professional sport. This is likely due to a combination of
well-established injury surveillance systems and the characteristics of the game, whereby high-impact
body contact frequently occurs, in addition to the high intensity, multispeed and multidirectional
nature of play. Some of the most severe of all these injuries are tendon and ligament/joint (non-bone),
and therefore, potentially the most debilitating to a player and playing squad across a season or
World Cup competition. The aetiology of these injuries is highly multi-factorial, with a growing
body of evidence suggesting that some of the inter-individual variability in injury susceptibility
may be due to genetic variation. However, little effort has been devoted to the study of genetic
injury traits within rugby athletes. Due to a growing understanding of the molecular characteristics
underpinning the aetiology of injury, investigating genetic variation within elite rugby is a viable
and worthy proposition. Therefore, we propose several single nucleotide polymorphisms within
candidate genes of interest; COL1A1, COL3A1, COL5A1, MIR608, MMP3, TIMP2, VEGFA, NID1 and
COLGALT1 warrant further study within elite rugby and other invasion sports.
Keywords: genomics; rugby; polymorphisms; soft-tissue injury; tendinopathy; ligament rupture
1. Introduction
Due to the characteristics of the game of rugby, whereby high-impact body contact frequently occurs
through multiple physical collisions and tackles, musculoskeletal injuries are extremely common [1,2].
Rugby Union (RU) has one of the highest reported incidences of match injuries within professional
sports, regardless of the injury definition used [3]. This is likely in part due to the well-established
and frequently applied injury surveillance research compared to other collision sports. Rugby League
(RL) does not currently have a comparable level of injury surveillance research which limits our
understanding somewhat. The majority of injuries in both RU and RL occur during tackles [1,4–8].
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Sports 2019, 7, 138 2 of 27
However, numerous other causes have been documented, including but not limited to rucks, mauls,
scrums [9] and via tripping, twisting, slipping, falling, overexertion, and overuse [10]. A meta-analysis
by Williams et al. [11] reported the total incidence of injury (injuries per 1000 player h) as 81/1000 in
matches (~3 injuries per match) and 3/1000 in training in men’s professional RU.
The regular occurrence of injury in RU limits competitive success. For example, Williams et al.’s [12]
recent seven-year prospective study assessing playing time loss from injury and team success in elite
RU found clear negative associations between injury measures (injury burden and injury days per
match) and team success (league points tally and Euro Rugby club ranking). Thus, reductions in injury
incidence and severity could enhance team success.
Due to the high incidence of injury in RU, numerous injury surveillance studies have been
conducted during international competitions, particularly during the five Rugby World Cups from 1995
to 2015 [7,8,13,14], as well as single and multiple seasons for professional [6,15,16] and community level
rugby [17,18]. Although numerous injury surveillance studies have been carried out in RU, only studies
from 2007 were consistent with the international consensus statement for epidemiological studies in
rugby [19]. Therefore, comparisons with earlier studies are problematic. This consistency has not
existed to the same degree for RL, although recent steps have been taken towards a consensus-driven
approach [20].
Injury data collection is an essential part of trying to understand the risk (incidence and severity)
of participation in sports and how that risk changes over time. van Mechelen et al. [21] designed a
four-step model for injury prevention within sport. It involves (i) identifying the extent of the sports
injury problem, (ii) identifying the characteristics and mechanisms that contribute to the development
of injury, (iii) introducing measures to reduce future risk and/or severity of injury, (iv) an evaluation
of those measures by repeating the first step. A similar risk management model was proposed by
Fuller and Drawer [22], which aimed to identify risk factors and estimates that could be evaluated and
then communicated to the sports community. Having a deeper understanding of these areas enables
coaches, doctors and strength and conditioning staff to assess current practices in injury prevention,
treatment, and rehabilitation, and make adjustments accordingly. It also allows governing bodies to
identify areas of high risk and to introduce strategies to mitigate such a risk. Finally, longitudinal
injury data allows researchers to monitor the impact and effectiveness of any interventions. What is
apparent from the research undertaken thus far is that injuries vary considerably in location, diagnosis
and profile.
Fundamental understanding of injury mechanisms and differences in inter-individual risk begins
with the genome and the biological composition of tissues that depend on coordinated expression of
selected genes at the protein level. Being able to utilize these genetic data alongside the traditional
injury prevention practices may enable a more personalized approach to injury risk management
at the elite level of rugby. The aim of this narrative review, therefore, is firstly to highlight the
incidence and severity rates of tendon and ligament injury within elite rugby. Secondly, to discuss the
biological composition of tendons and ligaments and how genomics may influence this and subsequent
predisposition to injury. The steps necessary to better understand the genomic aspects of injury within
elite rugby will then be considered. A structured literature search was performed for empirical research
studies and review articles. The search terms included “elite rugby injury”, “injury mechanisms in
rugby”, “tendon and ligament epidemiology”, “pathophysiology of tendon and ligament injury”,
“molecular characteristics of tendon and ligament injury”, “genetics of tendon and ligament injury”.
The reference lists of all articles were also examined for eligible studies to minimize the possibility of
relevant articles being omitted.
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2. Tendon and Ligament Injury Incidence Rates and Severity in Rugby
2.1. Tendon and Ligament Injury Incidence Rates in Rugby
Numerous injury surveillance studies have been carried out within professional RL, with
muscle/tendon and ligament/joint (non-bone) injuries consistently the two most frequent types of
injury [4,23–27]. However, the majority of professional RL studies are dated, have limited application to
present day RL, and inconsistent methodological approaches and definitions were used. Cross et al. [28]
demonstrated the importance of utilizing consistent definitions for injury by showing that incidence
of injury with a >24-hour time-loss definition was approximately double that when using a >7 day
definition. For example, Gissane et al.’s [23] injury definition was “the onset of pain or a disability
resulting from either training for or playing rugby league,” while Seward et al.’s [24] definition
was “that which caused a player to be unavailable for selection in a match, or participation in a
training session or any other injury which required medical treatment, other than routine conservative
measures.” These differences provide substantially different portrayals of injury risk. When the injury
definition is more exclusive and includes only more severe injuries, joint/ligament injuries are most
frequent. However, when the definition is more inclusive, muscular, head and neck injuries are most
frequent [2]. This has led to much debate on definitions of injury within RL [29–31]. A very recent
attempt was made at a consensus-driven approach to standardize epidemiological studies in RL [20],
and these data are probably more valid than those previously reported. Three different ligament
injuries were in the top five for incidence: medial collateral ligament (MCL) 3.9/1000 h, syndesmosis
2.7/1000 h, ankle lateral ligament 2.6/1000 h [20].
In RU, injury incidence rates are easier to identify than RL due to the consensus statement on
injury definitions and data collection procedures for studies in RU [19]. However, much like RL,
muscle/tendon and ligament/joint (non-bone) injuries are consistently the top two most frequently
occurring injury groups in elite RU [6–8,11,14,32] with more muscle/tendon injuries in backs than
forwards at English Premiership and International level. For ligament/joint (non-bone) injuries,
forwards appear to have more frequent occurrence at international level, while backs have more
at English Premiership level [6,7,14]. It should be noted, however, that these apparent differences
between forwards and backs are based on data provided in the literature but not statistical testing.
Table 1 summarizes the match injury incidence of muscle/tendon and ligament/joint (non-bone) injuries
from post-2007 studies where methodologies align with the consensus statement on injury definitions
and data collection procedures [19]. It is worth noting that, at World Cup competitions, although
muscle/tendon injuries have a high incidence, this is mainly due to the presence of muscle rather
than tendon injuries [7,8,14]. It is likely that this also occurs in the English Premiership and Super 14
competitions, but the data are not clear.
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Table 1. Muscle/tendon and ligament/joint (non-bone) injury incidence rates in elite rugby union.
Study Level Injury Type Match Injuries Incidence (Injuries/1000Player Hours (95% CI))
Main Group Sub-Group Forwards Backs All
Brooks et al. [6] 1,2
English Premiership clubs 4
Muscle/Tendon Strain/Tear/Rupture 14 * 20 * 17 *
Ligament/Joint
(non-bone) Sprain/Rupture 13 * 15 * 14 *
Fuller et al. [14]
International
Muscle/Tendon Muscle Rupture/Tear/Strain 18 (12–29) 27 (18–40) 22 (17–30)
Tendon rupture/Tendinopathy 0 1 (0.2–8) 0.5 (0.1–4)
Ligament/Joint
(non-bone) Sprain/Rupture 25 (17–37) 23 (15–36) 25 (18–33)
Fuller et al. [7] International Muscle/Tendon Muscle rupture/Tear/Strain 20 (13–30) 20 (13–32) 20 (14–27)
Tendon rupture/Tendinopathy 1 (0.1–7) 5 (2–12) 3 (1–6)
Ligament/Joint
(non-bone) Sprain/rupture 22 (14–33) 18 (11–29) 20 (14–27)
Moore et al. [32] International Muscle/Tendon Muscle strain/rupture - - 34 (23–49)
Tendinopathy/rupture - - 9 (4–18)
Ligament/Joint
(non-bone) Sprain/rupture - - 43 (31–61)
Fuller et al. [8] International Muscle/Tendon - 34 39 -
Ligament/Joint
(non-bone) - 25 34
Williams et al. [11] 3 English Premiership clubs 4,
Super 14 clubs 4, Vodacom cup
2008 clubs 4 and International
Muscle/Tendon - - - 40 (21–76)
Ligament/Joint
(non-bone) - - - 34 (18–65)
1 Study was before 2007 consensus statement on injury definitions and data collection procedures but used very
similar methods. 2 No confidence intervals were annotated in the study. 3 Meta-analysis with seven studies
used for pooled analysis [6,7,14,33–36]. 4 Top tier of professional rugby competitions in England, Australia, New
Zealand, and South Africa. * These data were calculated by totaling all reported injuries within muscle/tendon or
ligament/joint (non-bone), as Brooks et al. [6] only reported individual injuries rather than groups.
In the English Premiership RU competition across the seven most recently reported seasons from
2011–2018, ligament injuries were consistently amongst the top five most common injuries [16,37,38],
with MCL in the top five every season apart from 2015–2016. The Professional Rugby Injury Surveillance
Project (PRISP) reports individual injuries such as MCL, hamstring or ankle lateral ligament, rather
than grouping all muscle/tendon or ligament/joint (non-bone) injuries together. Outside of the top five
injuries, there are no available data on further muscle/tendon and ligament/joint (non-bone) injuries,
making more detailed or grouped analysis impossible. Figure 1 shows the top five most common
match injuries in the English Premiership competition during 2011–2018, highlighting the frequency of
ligament injuries.
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Figure 1. Top five most common injuries: English Premiership Rugby. Adapted from the Professional
Rugby Injury Surveillance Project (PRISP) annual reports 2011–2018 [38,39]. Key: Lined bars = ligament
injuries; squared bars = concussion; filled bars = any other injury.
2.2. Tendon and Ligament Injury Severity and Burden in Rugby
The current literature is limited regarding the severity (days absence from full training or match
play) of injuries at specific anatomical locations in elite RL. From the available data, Gibbs [40] found
ankle ligament tears were the most severe, followed by MCL tears and groin muscle/tendon tears. More
recently, Orchard [41] stated anterior cruciate ligament (ACL) tears were the most severe, followed by
shoulder sprains and dislocations and MCL tears. This is supported by Fitzpatrick et al. [20], although
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that study calculated severity from date of occurrence until date of return to full training, which
differs from the RU’s consensus statement on injury definitions and data collection procedures [19] and
would increase severity data. These studies suggest that ligament/joint (non-bone) and muscle/tendon
injuries are the main causes of RL players missing matches, thus impairing competitive success and
player wellbeing.
Rugby union has similar but more consistent findings to RL, with muscle/tendon and ligament/joint
(non-bone) injuries making up three of the top five most severe injuries for forwards; ACL, Achilles
tendon and MCL injuries caused 988, 726 and 718 days absence, respectively [6]. For backs, three of
the top five most severe were hamstring muscle, MCL, and ACL injuries causing 1176, 870 and 815
days absence, respectively [6]. Knee injuries in particular (ACL and MCL) resulted in the greatest
absence for forwards and backs [6]. At the 2007 RU World Cup, muscle/tendon (mainly muscle) and
ligament/joint (non-bone) were the third and fourth most severe injuries, with backs having a higher
severity of both [14] (not tested statistically). At the 2011 RU World Cup, ligament/joint (non-bone) and
muscle/tendon (mainly tendon) were the third and fourth most severe injuries with backs again having
a higher severity of both [7] (not tested statistically). Fuller et al. [8] identified knee ligament injuries
as the most severe and Achilles tendon injuries as the fourth most severe at the 2015 RU World Cup
for all players. In Williams et al.’s [11] meta-analysis, a similar pattern was seen, with ligament/joint
(non-bone) injuries the second most severe and muscle/tendon injuries the fourth. Table 2 summarises
the severity of muscle/tendon and ligament/joint (non-bone) injuries for English Premiership and
World Cup competitions. The large variability can be attributed to several factors such as different
settings (league or cup tournament), cohort sizes and opportunities for data collection.
Table 2. Muscle/tendon and ligament/joint (non-bone) injury severity rates in elite rugby union.
Study Level Injury Type Match Injuries Severity (Days Absence(95% CI))
Main Group Sub-Group Forwards Backs All
Brooks et al. [6] 1,2
English Premiership
clubs 5
Muscle/Tendon Strain/Tear/Rupture 20 # 16 # 17 #
Ligament/Joint
(non-bone) Sprain/Rupture 22
# 26 # 24 #
Fuller et al. [14]
International
Muscle/Tendon MuscleRupture/Tear/Strain 17 (10–25) 21 (9–33) 20 (12–27)
Tendon
Rupture/Tendinopathy 0 4 * 4 *
Ligament/Joint
(non-bone) Sprain/Rupture 14 (8–20) 18 (9–27) 16 (11–21)
Fuller et al. [7] International Muscle/Tendon MuscleRupture/Tear/Strain 15 (8–23) 27 (16–38) 21 (14–28)
Tendon
Rupture/Tendinopathy 4 * 36 (0–92) 29 (0–75)
Ligament/Joint
(non-bone) Sprain/Rupture 38 (8–68) 42 (12–72) 39 (18–61)
Fuller et al. [8] 2,3 International
Ligament/Joint
(non-bone) Knee Ligament - - 1507
Achilles Tendon - - 188 *
Williams et al. [11] 4 English Premiership
Clubs 5 and
International
Muscle/Tendon - - - 15 (5–24)
Ligament/Joint
(non-bone) - - - 29 (19–39)
1 Study was before 2007 consensus statement on injury definitions and data collection procedures in the rugby
union. 2 No confidence intervals reported in this study. 3 Study only reported injuries causing most days of absence
rather than mean severity across a main injury group. 4 Meta-analysis with four studies used for pooled analysis
[6,7,14,34]. 5 Top tier of professional rugby competitions in England. * Only one result in category. # These data are a
“weighted severity” utilizing the following equation: incidence x severity/incidence for all individual muscle/tendon
or ligament/joint (non-bone) injuries, as Brooks et al. [6] only reported individual injuries rather than groups.
For injury burden (days absence/1000 h), in the English Premiership competition across 2011–2018,
ligament/joint (non-bone) injuries dominated the top five highest risk match injuries. Three different
ligament injuries were usually in the top five highest risk injuries (all except 2015–2016 and 2017–2018
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when there were two), with ACL and MCL injuries included every season (apart from 2017–2018 when
ACL was not) [15,16,37,38]. Figure 2 features the top five highest risk injuries during 2011–2018.
Sports 2019, 7, x FOR PEER REVIEW 8 f 28 
 
Figure 2. Top five highest risk match injuries: English Premiership Rugby. Adapted from PRISP 
annual reports, 2011–2018 [38,39]. Key: lined bars = ligament injuries; squared bars = concussion; filled 
bars = any other injury. 
In elite rugby, muscle/tendon and ligament/joint (non-bone) injuries are some of the most severe 
and frequently occurring injuries players receive and are, therefore, extremely debilitating to playing 
squads. Generally, in elite RU, there appears to be a trend towards more severe injuries [39]. Whether 
this is due to the more conservative approach to injury management or increased damage caused by 
larger collisions remains to be established. A deeper understanding of the potential causes and, 
subsequently, any preventative measures against these injuries would be of great value to both 
governing bodies and medical staff. 
0 50 100 150 200 250 300 350 400 450
1. ACL
2. MCL
3. Hamstring muscle
4. Shoulder dislocation
5. PCL/LCL
1. Ankle syndesmosis
2. MCL
3. Hamstring muscle
4. ACL
5. Clavicle fracture
1. MCL
2. ACL
3. Concussion
4. Hamstring muscle
5. Ankle syndesmosis
1. ACL
2. Concussion
3. Hamstring muscle
4. Ankle syndesmosis
5. MCL
1. Concussion
2. ACL
3. AC joint
4. Hamstring muscle
5. Combined knee ligament
1. Concussion
2. Hamstring muscle
3. ACL
4. MCL
5. Ankle syndesmosis
1. Concussion
2. Hamstring muscle
3. MCL
4. Radial fracture
5. Ankle syndesmosis
20
11
-1
2
20
12
-1
3
20
13
-1
4
20
14
-1
5
20
15
-1
6
20
16
-1
7
20
17
-1
8
Days absence
/1000hours
Figure 2. Top five highest risk match injuries: English Premiership Rugby. Adapted from PRISP annual
reports, 2011–2018 [38,39]. Key: lined bars = ligament injuries; squared bars = concussion; filled bars =
any other injury.
In lite rugby, muscle/ten on nd ligament/joi t (non-bon ) injuries are ome of the most severe
and frequently occurring injuries players receive and are, therefore, extremely debilitating to playing
squads. Generally, in elite RU, there appears to be a trend towards more severe injuries [39]. Whether
this is due to the more conservative approach to injury management or increased damage caused
by larger collisions remains to be established. A deeper understanding of the potential causes and,
subsequently, any preventative measures against these injuries would be of great value to both
governing bodies and medical staff.
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3. Risk Factors for Injury in Rugby
From the available literature, it is difficult to state exactly how each muscle/tendon and
ligament/joint (non-bone) injury occurred during rugby matches or training. Nevertheless, the
most common causes of injury in RL and RU are tackles and physical collisions [42], with the ball
carrier generally at highest risk [43], though not for concussion [44]. Further risk factors for injury in
rugby identified in previous literature are: playing position [5,6], level of play [11], training volume
and load [45–47], ground conditions and playing surface [48], anthropometric characteristics [49,50],
previous injury [51] including concussion [52,53], physiological characteristics [11,50] and age [54]. The
precise mechanisms of tendon and ligament injury are not well understood [55,56], with multiple factors
probably involved [55,56]. It has been suggested that interactions between genetic and environmental
factors can amplify intrinsic risk factors (anthropometry, physiological characteristics, etc.) and place
a predisposed athlete at higher risk of injury once an inciting event occurs [55,57,58]. For example,
during typical physiological environments the matrix of ligaments and tendons will adapt in response
to load [59]. However, variation in the loading pattern such as higher strains or a higher volume of low
strains could lead to maladaptation, resulting in degeneration or a failed healing response [59], and
thus injury (Figure 3). The tolerable load varies between individuals, resulting in large inter-individual
variation in response to ligament and tendon tissue loading. This large inter-individual variation is
thought to be partly due to a genetic component [60], meaning some individuals are more predisposed
to ligament and tendon injury than others.
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4. Tendon and Ligament Pathologies
4.1. Tendinopathy
Tend ns, especially the Achilles, are designed to tolerate significant loads. Mechanical loading of
tendon leads to an increase in collagen gene expression and an upturn in collagen protein complex
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synthesis, which is likely regulated by the strain experienced by local tenocytes [62]. The increased
collagen formation peaks ~24 h after substantial mechanical loading, while the degradation of collagen
proteins also increases after loading but appears to peak earlier [62]. Thus, maintaining tendon
homeostasis is a finely tuned process, and despite a tendon’s ability to adjust to mechanical loading,
overuse will potentially result in injury such as tendinopathy.
Traditionally, “tendinitis” was the preferred term to describe chronic pain in a symptomatic
tendon, which implied that inflammatory processes played a central role in the disease aetiology.
However, treatment protocols designed to modify inflammation had limited success [63,64] and few or
no inflammatory cells were found in symptomatic tissue [65,66]. Therefore, the terms “tendinosis” or
more generally “tendinopathy” are now preferred [67]. Tendinopathy is a diverse clinical syndrome
associated with swelling, pain, impaired tissue healing and decreased performance [68]. There appears
to be a continuum between physiology and pathology; as such, overuse (e.g., excessive repetitive
loading of the tendon) could be considered the primary cause of disease [67].
Biomolecular studies of tendinopathy are relatively sparse although some observations have been
made. Increased expression of messenger RNA (mRNA) has been found for type I and III collagens
within symptomatic tendons [62,69]. This could reflect decreases in total collagen content (and a
biological attempt to compensate) and an increased ratio of type III collagen relative to type I [70–72].
This increased proportion of type III collagen within the main fiber bundles appears to reduce fibril
diameter [73], probably weakening the tendon and increasing risk of rupture [74].
Tendinopathies are caused by multiple intrinsic and/or extrinsic risk factors [55]. Common
intrinsic risk factors include age, anthropometry, sex, anatomical factors, hyperthermia, previous injury
and systemic diseases [75,76], with genetic variation also recently proposed [77]. Common extrinsic
risk factors include environmental conditions, shoes/surface, training errors, nutrition, medication
and mechanical loading [75–77]. Anatomical factors such as alignment and suboptimal biomechanics
could contribute to two-thirds of Achilles tendon disorders among athletes [78]. Low-level highly
repetitive strains below the failure threshold, or high strains even without great repetition, cause
tendon degeneration [79]. Thus, excessive loading during physical training is considered the primary
extrinsic determinant of tendon degeneration [80]. In the presence of intrinsic risk factors such as
genetic predisposition, excessive loading may therefore further increase the risk of tendinopathy.
There is no direct evidence of what causes tendinopathy in rugby players, although potential causes
include: differing ground conditions that change the magnitude and temporal characteristics of the
loads experienced; running and certain contact situations that elevate low-level repetitive loading;
tackling, scrums, and mauls that elicit high strain; excessive training and match volume (insufficient
recovery and/or excessive loading).
4.2. Tendon Rupture
Tendon rupture is an acute injury where partial or complete tearing of the tendon occurs. This is
observed at the microscopic and macroscopic level, whereas tendinopathy occurs without macroscopic
tearing [81]. Partial or complete rupture will inhibit tendon continuity, limiting range of motion and
force-generating capabilities. Extrinsic risk factors are thought to dominate tendon rupture incidence,
with intrinsic risk factors also considered important [82]. Intrinsic and extrinsic risk factors for tendon
rupture are similar to those mentioned for tendinopathy, although rupture often follows one isolated
overloading event [62,83–87]. In rugby, this is probably through high-loading scenarios such as scrums,
mauls, sprinting, tackling and landing from jumps. During loading, the crimping formation of the
collagen within the tendon is lost, and the collagen responds to the increasing load linearly [88].
Tendon strain >4% causes microscopic tearing of fibers and strain >8-10% causes macroscopic failure
and rupture [88,89]. The aetiology of tendon rupture is not completely understood [90]. However, it
appears to be multi-factorial, typically involving a combination of excessive loading and intrinsic risk
factors [91]. Histologically, degenerative tendinopathy is the most frequent finding in acute tendon
ruptures [92].
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4.3. Molecular Changes in Tendinopathy and Tendon Rupture
Gene expression is altered in symptomatic tendons. Increased mRNA expression has been
reported for proteoglycans such as aggrecan and biglycan [93], decorin and versican [94], glycoproteins
such as tenascin-C and fibronectin [62], angiogenic factors such as vascular endothelial growth factor
(VEGF) [95], collagen type I [94], tissue inhibitor of metallaoproteinase 1 (TIMP 1) and 2 [94], and
proteolytic enzymes such as the disintegrin and metalloproteinase (ADAM-12) [96], plus several
matrix metalloproteinases (MMPs 1, 2, 9, 13, and 23) [94,96]. Conversely, decreased mRNA expression
has been reported for TIMP3 and MMPs 3, 10, and 12 [96]. However, the molecular signature of
tendinopathy appears quite different from that of tendon rupture. Jones et al. [96] found lower mRNA
expression in ruptured than tendinopathic tendons of ADAMTS 2, 3 and 17, MMP 7, 16, 23, 24 and
28, as well as TIMP 2, 3, and 4, and increased expression of ADAMs 8 and 12, A disintegrin and
metalloproteinase with thrombospondin motifs 4, TIMP1, and MMPs 1, 8, 10, 12, 19, and 25. Such
differences in gene expression potentially contribute to disease pathophysiology [97].
Alterations in gene expression in symptomatic tendons suggests there is an interaction between
genes and environment and thus a genetic component to the aetiology of this disease. Indeed, in a twin
study of tennis elbow (epicondylitis) in women [98], heritability was estimated at ~40%. Furthermore,
several studies report associations between Achilles tendinopathy and several genetic variants, as
discussed in Section 6.
4.4. ACL Tear and Rupture
Injuries to the ACL are among the most frequent knee ligament injuries in sport and usually
require reconstruction [99,100]. In the RU, although ACL injuries are not the most frequent, they have
been in the top five most severe injuries for six of the last seven seasons in English Premiership Rugby
(2011–2018) [37,39], accounting for 224 days of absence/1000 h in 2016–2017 [37,39]. Frequently, ACL
injuries lead to muscle weakness, altered movement, joint effusion, reduced functional performance,
and have been associated with continuing clinical sequelae such as chondral lesions, meniscal tears
and increased risk of early-onset post-traumatic osteoarthritis [101–105].
Dallalana [106] established that the primary mechanisms of ACL injury in RU are a player
being tackled, tackling or in general collisions, accounting for 43%, 29% and 14% of all ACL injuries,
respectively. However, the remaining 14% of ACL injuries occurred through non-contact mechanisms
such as twisting and turning [106]. More recently, using video to analyze the mechanisms for ACL
injury in RU showed that 57% occurred through contact [107]. Two main scenarios were identified:
offensive running and being tackled, suggesting that the ball carrier is at increased risk of ACL injury.
The remaining 43% were through non-contact mechanisms, mainly sidestepping maneuvers. There
are numerous intrinsic and extrinsic risk factors for ACL injury, including age, anthropometry, sex,
previous injury, anatomical variation, neuromuscular and cognitive factors, and genetics [56,108–110]
for intrinsic risk factors. Whereas for extrinsic risk factors, environmental conditions, shoes/surfaces,
training errors, and mechanical errors would be common [56,108–110]. However, trauma to the knee is
a fundamental requirement [108,109].
It is possible for ACL injuries to be either partial tears or complete ruptures. Like tendon, when
load is placed through the ACL the crimping formation of collagen will stretch linearly with increasing
load [111]. Strains >4% cause microscopic tearing of the fibers and >8–10% strain cause macroscopic
failure and rupture [111]. Though high-traumatic strains are a typical cause of ACL rupture, microscopic
damage to ligament tissue occurs at relatively low levels of strain [112]. Furthermore, changes at
the microscopic level such as extra-cellular matrix (ECM) alterations and cellular damage alter the
mechanical properties of ligaments, thus when a ligament with microstructural alterations has strain
applied, rupture can follow [112]. Thus, ACL rupture may occur in the same manner as tendon rupture,
with prior degeneration of the tissue before the inciting event.
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4.5. Molecular Characteristics of ACL Tear and Rupture
Over the last ~25 years, numerous studies have examined genetic factors that potentially predispose
an individual to ACL injury [113–129]. Tears of the ACL seem at least twice as likely in individuals
with a family history of ACL tear compared to those with no family history [113,114]. To the authors’
knowledge, there have been no twin studies estimating the heritability of ligament injury, unlike
tendon [98]. In our opinion, this would be an extremely useful addition to the literature to develop an
understanding in this area. The majority of research into the genetics of ACL injury has utilized gene
association studies (GAS). From these studies, variants in several genes have been associated with
altered risk of ACL injury, as detailed in Section 6.
5. Genetics of Tendon and Ligaments
Genetic variation may have a strong influence on tendon and ligament structure and function,
which could alter an individual’s risk of injury. Inter-individual variability of tendon and ligament
properties is likely to cause microtrauma and macrotrauma at differing strain levels among individuals,
thus similar injury-inciting events amongst rugby players may have vastly different outcomes.
Published associations exist between gene variants (of proteins that play structural and functional
roles within tendons and ligaments) and susceptibility to injury for tendinopathy [130–140], tendon
rupture [140] and ACL rupture [116–122,125,127–129,139]. Therefore, due to the high incidence and
severity of tendon and ligament injuries within elite rugby, there is a potential future role for genetic
screening of players to aid in injury risk management, but the practicalities are yet to be developed.
In addition, the literature regarding genetic variants and tendon and ligament injuries is in its infancy,
with little replication. Currently, there are no studies examining the genetics of tendon and ligament
injuries within elite rugby.
6. Identifying Candidate Genes
Traditionally, top-down or unmeasured genotype approaches have been utilized to identify the
heritability of phenotypes. While these provide useful estimates for identifying the genetic influence
of certain phenotypes, they offer no evidence of the specific genes or polygenic profiles that contribute
to the phenotype. Furthermore, high-throughput approaches such as genome-wide association studies
(GWAS) frequently identify a variety of candidate genes, of which only a small percentage are actually
relevant to the phenotype of interest and validating all the identified candidate genes is not always
possible [141]. Genome-wide association studies also require particularly large sample sizes to be
effective and meet the generally accepted significance level of p < 5 × 10−8 to minimize the risk of
false positives, but that is not yet feasible in rugby. Thus, there is a need to study candidate genes
because an adequately powered GWAS is currently impossible, although judicious use of GWAS
results from other relevant populations to identify candidate genes can be fruitful [142]. A strength
of GAS is that selection of candidate genes is based on detailed knowledge of a protein and its role
vis-à-vis the phenotype of interest. Once a candidate gene is identified, the next logical step is to find
functionally significant polymorphisms, with priority given to non-synonymous (missense) single
nucleotide polymorphisms (SNPs) that change an amino acid in a protein or a nonsense variation that
creates a premature stop codon, as these are most likely to have substantial biological effects [143].
However, polymorphisms in regions of DNA that regulate the expression of genes have recently
become more appreciated for their functional roles [144,145]. Thus, several genes have been identified
that may influence injury risk and are worthy of study within elite rugby (Table 3).
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Table 3. Candidate genes, candidate proteins, and their abbreviations.
Candidate Protein Candidate Protein Abbreviation Candidate Gene Candidate Gene Abbreviations
Type I collagen Col I Collagen type I alpha I COL1A1
Type III collagen Col III Collagen type III alpha I COL3A1
Type V collagen Col V Collagen type V alpha I COL5A1
N/A Non-coding RNA N/A MicroRNA 608 MIR608
Matrix
metalloproteinase-3 MMP3 Matrix metalloproteinase-3 MMP3
Tissue inhibitors of
metalloproteinases-2 TIMP2
Tissue inhibitors of
metalloproteinases-2 TIMP2
Vascular endothelial
growth factor A VEGFA
Vascular endothelial
growth factor A VEGFA
Nidogen 1 NID1 Nidogen 1 NID1
Collagen beta(1-O)
galactosyltransferase 1 COLGALT1
Collagen beta(1-O)
galactosyltransferase 1 COLGALT1
6.1. COL1A1 as a Candidate Gene
The gene COL1A1 codes for the α1 chain of Col I, which is responsible for the high tensile strength
of tendons and ligaments via its strong parallel fiber bundles and cross-linking formation [146]. Several
studies have investigated associations between the Sp1 polymorphism (rs1800012) and a variety of
soft tissue injuries; including cruciate ligament ruptures, Achilles tendinopathy and rupture, shoulder
dislocation and tennis elbow (Table 4). Individuals of TT genotype appear to be at lower risk of cruciate
ligament injury, particularly the ACL [115,116,122]. In contrast, there seems to be no association
between tendinopathies or tendon rupture and the Sp1 polymorphism [147].
Table 4. COL1A1 rs1800012 genetic association studies with tendon and ligament injuries in humans.
Study Phenotype Target Population Participants Findings
Khoschnau et al. [115]
Cruciate ligament
ruptures, shoulder
dislocations
Sweden
No ethnicity reported.
233 cruciate ligament injury
participants,
126 shoulder dislocation
participants,
325 female controls
Individuals with TT
genotype had a reduced risk
of injury for cruciate
ligament ruptures and
shoulder dislocations
compared to GG carriers.
Posthumus et al. [116] ACL injuries SA
Caucasian,
117 ACL rupture participants,
130 controls
TT genotype
underrepresented in ACL
injury group compared to
controls.
Posthumus et al. [147]
Achilles
tendinopathy,
Achilles tendon
ruptures
SA
Caucasian,
85 Achilles tendinopathy
participants,
41 participants with partial or
complete ruptures,
126 controls
No differences in genotypes.
Ficek et al. [122] ACL injuries Poland
Caucasian,
91 professional football players
with ACL rupture—all
non-contact,
143 apparently healthy
professional soccer players as
controls
No differences in genotypes.
There was an
overrepresentation of G–T
haplotypes (1997G+1245T)
in controls suggesting,
carriers may have reduced
risk of injury.
Ste˛pien-Słodkowska et al. [121] ACL injuries Poland
No ethnicity reported,
138 male recreational skiers with
ACL rupture,
183 apparently healthy male
skiers as controls
Carriers of the GG genotype
were at lower risk of ACL
injury than carriers of the TT.
genotype.
Erduran et al. [148] Tennis elbow Turkey
No ethnicity reported,
103 with tennis elbow,
103 apparently healthy controls
No differences in genotypes.
Key: SA = South Africa.
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6.2. COL3A1 as a Candidate Gene
The protein Col III is an important fibrillar collagen that is similar in structure to Col I. However,
Col III is a homotrimeric molecule (three α1 (III) chains) as opposed to the heterotrimeric form of
Col I [149,150]. Col III frequently mixes with Col I to form mixed fibrils and is also plentiful in
elastic tissue [151]. Specifically, it is found in the solid component of tendons and ligaments [152],
where it functions with Col I, V, and XII to enable normal collagen fibrillogenesis [153,154]. The
pro-α1 chains of Col III are encoded by the COL3A1 gene. Three studies have investigated the
association between COL3A1 and ACL rupture (Table 5), but none have examined tendon pathology.
Ste˛pien´-Słodkowska et al. [129] found the AA genotype of the COL3A1 rs1800255 polymorphism was
more common in male recreational Polish skiers with ACL rupture than apparently healthy skiers.
Similar evidence was found in Polish professional footballers [127], but not replicated in a broader
population [155]. Collectively, these results suggest that individuals involved in sport who carry the
AA genotype may have increased risk of ACL rupture.
Table 5. COL3A1 rs1800255 genetic association studies with tendon and ligament injuries in humans.
Study Phenotype Target Population Participants Findings
Stephien-Slodkowska et al. [129] ACL rupture Poland
No ethnicity reported,
138 male recreational
skiers with ACL
ruptures,
183 male apparently
healthy skiers
The AA genotype was
overrepresented in the
ACL group compared to
controls.
O’Connell et al. [127] ACL rupture SA/ Poland
Caucasian.
333 participants with
ACL rupture (242 SA
and 91 Poland),
378 apparently healthy
controls (235 SA and 143
Poland).
No differences in
genotype frequency
distributions between
the SA ACL group and
the SA control group.
However, the AA
genotype was
overrepresented in the
Polish ACL group
compared to Polish
controls. No allele
associations for any of
the groups.
Kim et al. [155] ACL rupture
Caucasian,
Latin-American, East
Asian, African,
South-East Asian.
5148 Achilles tendon
injury participants,
97,831 apparently
healthy controls,
598 ACL rupture
participants,
98,744 apparently
healthy controls,
No associations after
Benjamini–Hochberg
correction for testing
multiple hypotheses.
Key: SA = South Africa.
6.3. COL5A1 as a Candidate Gene
Probably the most explored gene regarding tendon and ligament injury is COL5A1 (Table 6),
which encodes the α1 chains of type V collagen. The protein Col V is a minor fibrillar collagen that is
known to associate with type I and III collagen [156]. Although Col V is a minor collagen in terms of
content, research suggests that it functions as a major collagen in developing connective tissues [157].
Mokone et al. [131] were the first to associate the COL5A1 gene with Achilles tendon pathology, finding
the C allele of the rs12722 polymorphism less common in those with injury. This association was
replicated for Achilles tendinopathy [158] and ACL rupture in females [117], with the C allele also
underrepresented in tennis elbow patients versus controls [159]. These findings suggest the C allele
may be protective against tendon and ligament injuries. A recent investigation by the RugbyGene
Sports 2019, 7, 138 14 of 27
project [160] found differences in allele and genotype frequencies for the COL5A1 rs12722 and rs3196378
polymorphisms between elite rugby athletes (rs12722: CC genotype = 21%, C allele = 47%; rs3196378:
CC genotype 23%, C allele = 48%) and non-athletes (rs12722: CC genotype: 16%, C allele = 41%;
rs3196378: CC genotype = 16%, C allele = 41%, p ≤ 0.02) [161]. These findings suggest that elite rugby
players may have an inherited resistance against soft-tissue injury.
Table 6. COL5A1 rs12722 genetic association studies with tendon and ligament injuries in humans.
Study Phenotype Target Population Participants Findings
Mokone et al. [131]
Achilles tendon
pathology, Achilles
tendinopathy,
Achilles tendon
rupture
SA
Caucasian,
111 participants with current
or past history of Achilles
tendon pathology,
including 72 chronic
tendinopathy participants,
39 Achilles tendon rupture
participants
The frequency of the A2 (C)
allele was higher in the controls
compared to the Achilles tendon
pathology group. An even
stronger protective role was
seen for the A2 (C) allele in in
controls compared to the
chronic tendinopathy patients.
September et al. [158] Achillestendinopathy SA/Australia
Caucasian,
83 Australian and 93 SA
tendinopathy patients,
210 Australian, and 132 SA
controls
Individuals with CC genotype
in both populations
(Australian/SA) had a reduced
risk of developing Achilles
tendinopathy compared to any
other genotypes.
Posthumus et al. [162] ACL injuries SA
Caucasian,
129 ACL rupture
participants,
216 physically active
controls with no history of
ACL injury
The CC genotype was
underrepresented in the female
ACL rupture group, but not in
the male.
Stepien–Slodkowska et al. [128] ACL injuries Poland
No ethnicity reported,
138 male recreational skiers
with ACL ruptures,
183 apparently healthy male
recreational skiers without
any reported history of
ligament or tendon injury.
No differences in genotype
distribution between groups.
Higher frequency of rs12722 C-T
and rs13946 C-T polymorphisms
haplotype in controls suggests
reduced risk of ACL injury.
Altinisik et al. [159] Tennis elbow Turkey
No ethnicity reported,
152 tennis elbow patients,
195 healthy controls.
Individuals with the A2 (C)
allele were underrepresented in
patient group. Individuals with
A1 allele (T) have an increased
risk of developing tennis elbow.
Brown et al. [163]
Achilles
tendinopathy,
Achilles tendon
rupture
UK
Caucasian,
87 Achilles tendinopathy
participants,
25 Achilles tendon rupture
participants,
130 asymptomatic controls
No independent differences
found between groups. Three
inferred allele combinations
from rs12722, rs3196378, and
rs71746744 were identified as
risk modifiers. The T–C–D
combination was associated
with increased risk of Achilles
tendon pathology and rupture,
the C–A–I combination was
associated with increased risk of
Achilles tendon pathology,
tendinopathy and rupture, the
C–C–D combination was
associated with decreased risk
of Achilles tendon pathology
and rupture.
Kim et al. [155]
Achilles
tendinopathy,
Achilles tendon
rupture
Caucasian, Latin-American,
East Asian, African,
South-East Asian,
5148 Achilles tendon injury
participants,
97,831 apparently healthy
controls,
598 ACL rupture
participants,
98,744 apparently healthy
controls
No associations after
Benjamini–Hochberg correction
for testing multiple hypotheses.
Key: SA = South Africa.
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6.4. MIR608 as a Candidate Gene
MicroRNAs (miRNA) are a class of small non-coding RNAs that induce gene silencing and
translational repression [164,165]. Allele-specific polymorphisms within miRNA target sites influence
the tissue-specific miRNA regulation of hundreds of genes, which implies that their genetic variation
may be a prevalent cause of inter-individual phenotypic variability [166]. This potential variance has
been seen in the microRNA 608 (MIR608) gene, which was associated with altered risk of Achilles
tendinopathy [135,155,163]. To date, three studies have investigated the link between the MIR608
rs4919510 polymorphism and Achilles tendon pathology (Table 7), with none examining ACL rupture.
The latest investigation involved a genome-wide approach; Kim et al. [155] observed that although
MIR608 rs4919510 did not approach genome-wide significance (p < 5 × 10−8), when covariates such as
age, sex and ancestry were not used in analysis of a tentative association identified (p = 5.1 × 10−3).
The combined results from the three studies suggest that MIR608 may have a role in altering tendon
injury risk but the evidence is inconclusive.
Table 7. MIR608 rs4919510 genetic association studies with tendon and ligament injuries in humans.
Study Phenotype Target Population Participants Findings
Abrahams et al. [135] Achillestendinopathy SA/Australia
Caucasian,
160 chronic Achilles
tendinopathy
participants,
342 apparently healthy
controls
The CC genotype frequency of
rs4919510 was overrepresented
compared to the CG and GG
genotypes. The combined
rs4919510 CC genotype and
COL5A1 rs3196378 CA genotype
was overrepresented in the tendon
group compared to controls.
Furthermore, the rs4919510 CC
genotype and the COL5A1
rs3196378 A allele was
overrepresented in the tendon
group compared to controls.
Brown et al. [163]
Achilles
tendinopathy and
Achilles tendon
rupture
UK
Caucasian,
112 Achilles tendon
pathology participants
(87 chronic Achilles
tendinopathy and 25
Achilles tendon rupture,
130 apparently healthy
controls
No differences in genotype
frequency or allele frequency
distributions between Achilles
tendinopathy and controls.
However, the CG genotype of
rs4919510 was associated with
decreased risk of rupture
compared to controls. When
inferred allele combinations were
analyzed for rs4919510 and
COL5A1 rs3196378, and no
associations found with risk of
Achilles tendinopathy.
Kim et al. [155]
Achilles
tendinopathy,
Achilles tendon
rupture
Caucasian,
Latin-American, East
Asian, African,
South-East Asian,
5148 Achilles tendon
injury participants,
97,831 apparently
healthy controls,
598 ACL rupture
participants,
98,744 apparently
healthy controls
Moderate–weak evidence of
replication (p = 5.1 × 10−3) for
Achilles tendinopathy or rupture,
but no replication with ACL
rupture, after
Benjamini–Hochberg correction
for testing multiple hypotheses.
Key: SA = South Africa.
6.5. MMP3 as a Candidate Gene
The protein MMP3, encoded by the MMP3 gene, has a fundamental role in the regular
development, repair, and remodeling of connective tissues, by regulating ECM homeostasis via
proteolytic activity [167]. Several studies have examined the association between polymorphisms
rs679620, rs591058 and rs650108 within MMP3 and Achilles tendon pathologies and ACL ruptures
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(Table 8). These three polymorphisms span most of the MMP3 gene as they are within all four major
haploblocks (one exon SNP rs679620, two intron SNPs rs591058, rs650108) [167]. Raleigh et al. [132]
first investigated the three polymorphisms, finding all three independently associated with increased
risk of Achilles tendinopathy, specifically the GG genotype of rs679620, CC genotype of rs591058,
and AA genotype of 650108. The GG genotype of rs679620 has also been associated with Achilles
tendon rupture [140]. Conversely, Posthumus et al. [120] and Gibbon et al. [168] found no independent
associations between any of these variants and Achilles tendinopathy [168] or ACL rupture [120,168].
However, when inferred haplotype was considered, Posthumus et al. [120] and Gibbon et al. [168]
found they were associated with ACL rupture and Achilles tendinopathy, respectively. Interestingly,
Gibbon et al. [168] found the G (rs679620), C (rs5901058) and G (rs650108) alleles were overrepresented
in controls, which contrasts with previous findings [132] but aligns with a recent study of Achilles
tendon rupture, ACL tears and tendinopathy in a broader population [155]. Therefore, the literature
appears to suggest the chromosomal region 11q22 has some influence on musculoskeletal injuries,
most likely polygenic in nature, and warrants further investigation.
Table 8. MMP3 rs679620, rs591058 and rs650108 genetic association studies with tendon and ligament
injuries in humans.
Study Phenotype Target Population Participants Findings
Raleigh et al. [132]
Achilles
tendinopathy and
rupture
SA
Caucasian,
114 Achilles tendon pathology
patients including 75 with
Achilles tendinopathy and 39
with partial or complete rupture,
98 controls
Independent associations between the GG
genotype of rs679620, the CC genotype of
rs591058, and the AA genotype of rs650108 and
Achilles tendinopathy. The ATG haplotype
(rs679620, rs591058, and rs650108) was
under-represented in the tendinopathy
compared to controls. No associations between
MMP3 variants and Achilles tendon rupture.
Posthumus et al. [120] ACL rupture SA
Caucasian,
129 ACL rupture patients,
216 apparently healthy controls
No independent associations for rs679620
compared to controls. Haplotypes T-1G-A-A
and C-2G-G-G (MMP10 rs485055, MMP1
rs1799750, MMP3 rs679620, and MMP12
rs2276109) were different between control and
ACL groups and controls and non-contact
subgroup, respectively.
El Khoury et al. [140]
Achilles
tendinopathy and
rupture
UK
Caucasian.
118 Achilles tendon pathology
patients including 93 with
Achilles tendinopathy and 25
participants with partial or
complete rupture,
131 asymptomatic controls
rs679620 GG genotype overrepresented in
Achilles tendon rupture group compared to
controls. No association with Achilles
tendinopathy.
Gibbon et al. [168]
Achilles
tendinopathy ACL
rupture
Australia/SA
White Caucasian,
160 Achilles tendinopathy
patients,
195 apparently healthy controls,
234 ACL rupture patients,
232 apparently healthy controls
No independent differences for rs679620,
rs591058 and 650108 between Achilles
tendinopathy and controls or between ACL
rupture and controls. Haplotype 6a-G-C-G
(rs3205058, rs679620, rs591058 and rs650108)
overrepresented in the control group compared
to the Achilles tendinopathy group when only
Australian samples analyzed. No genotype or
allele frequency differences from inferred
haplotypes for ACL injury.
Kim et al. [155]
Achilles
tendinopathy,
Achilles tendon
rupture
Caucasian, Latin-American, East
Asian, African, South-East
Asian.
5148 Achilles tendon injury
participants.
97,831 apparently healthy
controls,
598 ACL rupture participants,
98,744 apparently healthy
controls
No associations after Benjamini–Hochberg
correction for testing multiple hypotheses.
Key: SA = South Africa.
6.6. TIMP2 as a Candidate Gene
The TIMPs are natural inhibitors of MMPs, which they bind with in a 1:1 stoichiometry [169].
In pathological conditions such as Achilles tendinopathy where irregular MMP activity occurs,
alterations in TIMP are important as they directly influence MMP activity [169]. The SNP TIMP2
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rs4789932 was associated with Achilles tendon pathologies in two studies [137,140] (Table 9). However,
they contain opposing findings with the CT genotype associated with Achilles tendon pathology
one [137], but overrepresented in controls in another [140]. Recently, Kim et al. [155] reported no
association after corrections for testing multiple hypotheses, but possibly adds a little support to the
data of El Khoury et al. [140]. Thus, although at present it is unclear which genotype/allele within the
TIMP2 polymorphism affects tendon injury risk, the evidence tentatively suggests that it may play
a role.
Table 9. TIMP2 rs4789932 genetic association studies with tendon and ligament injuries in humans.
Study Phenotype Target Population Participants Findings
El Khoury et al. [137]
Achilles
tendinopathy and
rupture
SA/Australia
Caucasian,
173 Achilles tendon
pathology participants
of which 134 with
Achilles tendinopathy
and 39 with partial or
complete rupture,
248 asymptomatic
controls
Association between TIMP2
rs4789932 and Achilles tendinopathy.
The CC variant was overrepresented
within controls, while the CT variant
was overrepresented within the
combined Achilles tendon pathology
group. No differences between the
rupture group and controls.
El Khoury et al. [140]
Achilles
tendinopathy and
rupture
UK
Caucasian,
118 Achilles tendon
pathology participants
of which 93 had
chronic Achilles
tendinopathy and 25
participants with
Achilles tendon
rupture,
131 asymptomatic
controls
Difference in genotype frequency
between male Achilles tendon
pathology compared to male controls.
Further, difference between male
ruptures compared to controls. The
CT genotype was associated with
lower risk of Achilles tendon
pathology.
Kim et al. [155]
Achilles
tendinopathy,
Achilles tendon
rupture
Caucasian,
Latin-American, East
Asian, African,
South-East Asian
5148 Achilles tendon
injury participants,
97,831 apparently
healthy controls
598 ACL rupture
participants,
98,744 apparently
healthy controls.
No associations after
Benjamini–Hochberg correction for
testing multiple hypotheses.
Key: SA = South Africa.
6.7. VEGFA as a Candidate Gene
Angiogenesis is essential during the repair and remodeling of injured tendons, although it can
also potentially reduce mechanical stability due to the proteolytic activity in the ECM by invading
endothelial cells [170]. Vascular endothelial growth factor (VEGF) is an endothelial cell mitogen that
stimulates angiogenesis [171,172]. It activates endothelial cells and vascular smooth muscle migration
and proliferation, as well as enhancing endothelial cell survival and differentiation [173]. Vascular
endothelial growth factor has a number of isoforms (A–D); the most relevant being VEGFA [173]
encoded by the VEGFA gene. Variants within VEGFA have been associated with ACL rupture [125]
and Achilles tendinopathy [174] (Table 10). Interestingly, a polymorphism appears to play a different
role in acute (ACL rupture) and chronic (Achilles tendinopathy) injury. The CC variant of rs699947
was overrepresented in non-contact ACL ruptures compared to controls, suggesting a role in increased
ACL rupture risk [125]. Yet the CC variant might protect against Achilles tendinopathy, being
underrepresented in a control population versus an Achilles tendinopathy group [174]. Further
investigation is needed to improve understanding of its role in musculoskeletal injury.
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Table 10. VEGFA rs699947 genetic association studies with tendon and ligament injuries in humans.
Study Phenotype Target Population Participants Findings
Rahim et al. [125] ACL rupture SA
Caucasian.
227 ACL rupture
participants,
227 apparently healthy
controls with no history of
ACL injury
The CC genotype of rs699947 was
overrepresented in participants with
non-contact ACL ruptures compared
to controls. The rs1570360 GA
genotype was overrepresented within
controls. The A-A-G haplotype
(rs699947, rs1570360 and 2010963)
was overrepresented in the control
group compared to the non-contact
ACL group.
Rahim et al. [174] Achillestendinopathy SA/UK
Caucasian,
195 chronic Achilles
tendinopathy participants
(87 from SA, 108 UK), 250
asymptomatic controls
(120 SA, 130 from UK)
The CC genotype of rs699947 was
overrepresented in the SA control
group compared to the SA
tendinopathy group. No other
independent frequency differences
found. The VEGFA A-G-G inferred
haplotype (rs699947, rs1570360, and
rs2010963) was associated with
increased risk of tendinopathy in the
SA group and the SA and UK
combined group.
Rahim et al. [175] ACL rupture SA
SA colored ethnic group
(unique to Western Cape
of SA),
98 ACL rupture
participants,
100 physically active
asymptomatic controls
with no history of tendon
or ligament injury
No differences in genotype or allele
frequency data for any of the VEGFA
polymorphisms studied. Further, no
associations found from inferred
haplotype analysis.
Key: SA = South Africa.
6.8. Additional Candidate Genes of Interest
Several genetic variants recently identified in a GWAS [155] are worthy of future study, such
as COLGALT1 rs8090 and NID1 rs4660148. These had strongest associations with ACL rupture
(p = 6 × 10−4) and Achilles tendon injury (p = 5 × 10−5), respectively, although none approached
genome-wide significance (p < 5 × 10−8). Inevitably, there will be many other as yet unidentified
genetic variants that emerge as research advances.
7. Future Directions/Conclusions
The exact pathophysiology of tendon and ligament injuries is yet to be fully elucidated, as they
are complex multifactorial conditions. There appears to be growing evidence of a genetic influence,
although much stronger evidence is needed. The genes mentioned within this text and many others
should be explored further regarding their relevance to tendon and ligament injuries. This would be
particularly useful in a sport such as rugby, due to its high incidence and severity of injury.
To be truly relevant to elite rugby, research must involve appropriate cohorts who possess the
extreme phenotypes and behaviors only found at the elite level. Elite athletes undergo heavy training
loads and are likely to exhibit characteristics near the limits of human physiological capability; indeed,
elite rugby has one of the highest incidences of injury in sport, with tendon and ligament injuries some
of the most frequent and severe. Regular participation at the elite level in rugby would mean players
have been exposed to one of the highest levels of risk for tendon and ligament injury in any professional
sporting environment, and at least to some extent, have been able to succeed in that sport despite that
high environmental risk. This ability to recover from or withstand musculoskeletal soft tissue injury
that is potentially performance-limiting or career-ending, but nevertheless achieve elite status, may
be reflected in distinct genetic characteristics. Large sample sizes are required for genetic research to
gain sufficient statistical power and reduce the likelihood of statistical errors. Additionally, the sample
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sizes should be in the hundreds and ideally thousands (especially if GWAS or other hypothesis-free
approaches are to be used), which is extremely challenging due to the limited number of elite athletes
in a given sport. Therefore, large international collaborations are required to achieve this aim within
rugby [160]. Accordingly, genetic analyses of players already included in large rugby injury databases
could prove fruitful in explaining some of the currently unexplained inter-individual variability in
injury susceptibility and may provide new markers of injury risk within elite rugby. Such findings
could then be applied alongside existing non-genetic data to aid the personalized management of
playing load and injury risk amongst rugby players.
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